NCT04582916View on ClinicalTrials.gov

PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)

PHASE1RecruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

July 20, 2021

Primary Completion Date

October 3, 2029

Study Completion Date

April 11, 2030

Conditions
Depression
Interventions
DRUG

11C-MCI

Injected IV followed by PET scanning

DRUG

11CPS13

Injected IV followed by PET scanning

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Mental Health (NIMH)

NIH